Intelligence Β· Patent portfolio

Axsome Therapeutics Patents

Full USPTO pharma patent portfolio for Axsome Therapeutics β€” grant dates, expiration, and drug cross-links.

Patents
162
Expiring ≀24m
0

Quick answer

Axsome Therapeutics has 162 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 4

  1. US 11129895

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11129826

    Bupropion as a modulator of drug activity

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11123344

    Bupropion as a modulator of drug activity

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11123431

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11110173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11077117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11045549

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 11020402

    Use of reboxetine to treat narcolepsy

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 11020483

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 11013805

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 11013806

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 10987358

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 10940153

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 10933136

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 10933137

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 10918722

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 10905693

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 10894053

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 10821181

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 10821182

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 10799588

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 10780165

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 10780166

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 10758617

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 10758618

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 10729697

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 10729774

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 10729696

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 10729773

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 10722583

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 10702602

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 10702535

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 10695429

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 10695304

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 10695430

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 10688185

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 10688102

    Combination treatment for migraine and other pain

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 10653777

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 10583144

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 10583088

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 10561664

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 10537642

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 10532101

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 10517950

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 10512692

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 10512693

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 10485871

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 10471069

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

162 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory